371 related articles for article (PubMed ID: 27289201)
1. Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care.
Thompson W; Hogel M; Li Y; Thavorn K; O'Donnell D; McCarthy L; Dolovich L; Black C; Farrell B
J Am Med Dir Assoc; 2016 Jul; 17(7):673.e1-4. PubMed ID: 27289201
[TBL] [Abstract][Full Text] [Related]
2. Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines.
Farrell B; Richardson L; Raman-Wilms L; de Launay D; Alsabbagh MW; Conklin J
Res Social Adm Pharm; 2018 Jan; 14(1):18-25. PubMed ID: 28214150
[TBL] [Abstract][Full Text] [Related]
3. We have had a gutful: The need for deprescribing proton pump inhibitors.
Naunton M; Peterson GM; Deeks LS; Young H; Kosari S
J Clin Pharm Ther; 2018 Feb; 43(1):65-72. PubMed ID: 28895169
[TBL] [Abstract][Full Text] [Related]
4. Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System.
Mafi JN; May FP; Kahn KL; Chong M; Corona E; Yang L; Mongare MM; Nair V; Reynolds C; Gupta R; Damberg CL; Esrailian E; Sarkisian C
J Am Geriatr Soc; 2019 Dec; 67(12):2600-2604. PubMed ID: 31486549
[TBL] [Abstract][Full Text] [Related]
5. Deprescribing in a family health team: a study of chronic proton pump inhibitor use.
Walsh K; Kwan D; Marr P; Papoushek C; Lyon WK
J Prim Health Care; 2016 Jun; 8(2):164-71. PubMed ID: 27477559
[TBL] [Abstract][Full Text] [Related]
6. Trends in prescribing patterns of proton pump inhibitors surrounding new guidelines.
Abrahami D; McDonald EG; Schnitzer M; Azoulay L
Ann Epidemiol; 2021 Mar; 55():24-26. PubMed ID: 33338647
[TBL] [Abstract][Full Text] [Related]
7. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
McIntyre C; McQuillan R; Bell C; Battistella M
Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
[TBL] [Abstract][Full Text] [Related]
8. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
Moriarty F; Bennett K; Cahir C; Fahey T
J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors.
Reeve E; Andrews JM; Wiese MD; Hendrix I; Roberts MS; Shakib S
Ann Pharmacother; 2015 Jan; 49(1):29-38. PubMed ID: 25385826
[TBL] [Abstract][Full Text] [Related]
10. Inappropriate proton-pump inhibitor prescribing in primary care - an observational study with quality circles.
Vidonscky Lüthold R; Henz NC; Fuhrer C; Häner A; Schenk M; Jungo KT; Streit S
Swiss Med Wkly; 2023 Sep; 153():40119. PubMed ID: 37769322
[TBL] [Abstract][Full Text] [Related]
11. [Impact of an evaluation of the professional practices on the relevance of proton pump inhibitors prescriptions pertinence at the hospital].
Daumas A; Garros E; Mendizabal H; Gayet S; Bernard F; Bagnères D; Demoux AL; Rossi P; Villani P; Granel B
Rev Med Interne; 2018 Aug; 39(8):618-626. PubMed ID: 29628172
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.
Nguyen-Soenen J; Rat C; Gaultier A; Schirr-Bonnans S; Tessier P; Fournier JP
BMC Health Serv Res; 2022 Feb; 22(1):219. PubMed ID: 35177042
[TBL] [Abstract][Full Text] [Related]
13. Development and Implementation of a Pharmacist-Led Proton Pump Inhibitor Deprescribing Algorithm in a Geriatric Ambulatory Office.
Leszcynski L; Bente J
Sr Care Pharm; 2023 Mar; 38(3):105-112. PubMed ID: 36803698
[No Abstract] [Full Text] [Related]
14. Long-term use of proton pump inhibitors and prevalence of disease- and drug-related reasons for gastroprotection-a cross-sectional population-based study.
Wallerstedt SM; Fastbom J; Linke J; Vitols S
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):9-16. PubMed ID: 27859947
[TBL] [Abstract][Full Text] [Related]
15. The impact of deprescribing interventions on oral proton pump inhibitor utilisation in a Singapore tertiary hospital: A quality improvement initiative.
Tan CJY; Lee SX; Ng TM
Ann Acad Med Singap; 2022 Jan; 51(1):8-15. PubMed ID: 35091726
[TBL] [Abstract][Full Text] [Related]
16. Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks.
Soubra L; Issa M
Int J Pharm Pract; 2019 Aug; 27(4):386-392. PubMed ID: 30942513
[TBL] [Abstract][Full Text] [Related]
17. Implementation of a Guideline to Decrease Use of Acid-Suppressing Medications in the NICU.
Angelidou A; Bell K; Gupta M; Tropea Leeman K; Hansen A
Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29162657
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the prescription of proton pump inhibitors in persons aged 75years and older in a geriatric acute-care unit].
Dipanda M; Pioro L; Buttard M; d'Athis P; Asgassou S; Putot S; Deïdda M; Laborde C; Putot A; Manckoundia P
Therapie; 2017 Dec; 72(6):669-675. PubMed ID: 28939010
[TBL] [Abstract][Full Text] [Related]
19. Quantifying Candidacy for Deprescribing of Proton Pump Inhibitors among Long-Term Care Residents.
Doell A; Walus A; To J; Bell A
Can J Hosp Pharm; 2018; 71(5):302-307. PubMed ID: 30401996
[TBL] [Abstract][Full Text] [Related]
20. Deprescribing in Primary Care in Singapore: Barriers and Facilitators.
Chia HS; Bek ESJ
Consult Pharm; 2018 Nov; 33(11):637-648. PubMed ID: 30458906
[No Abstract] [Full Text] [Related]
[Next] [New Search]
